The offering provides near-term cash but at significant dilution and with a large warrant overhang. Monitor the October 30 PDUFA date for INO-3107 and any updates on cash runway. The stock may face continued pressure from the overhang of 48.4M exercisable warrants at $1.10.
INO drugs
INO drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 31 $0.6770entry
- T+1 · 4mo ago +2.92%α +1.50% · $0.6968
- T+5 · 3mo ago −1.33%α −4.84% · $0.6680
- T+20 · 3mo ago +90.55%α +87.56% · $1.29
- T+60 · 22d ago +28.48%α +26.02% · $0.8698
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Inovio Pharmaceuticals priced a $20M public offering of 21M shares and warrants for 42M shares (or pre-funded warrants) at $0.95/unit, with net proceeds of ~$18.3M. The underwriter exercised an option for additional warrants covering 6.3M shares. This dilutive capital raise follows a prior going-concern disclosure and adds ~30% immediate dilution plus significant warrant overhang, reinforcing the bearish outlook.
Key Facts
- Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $0.95/unit
- Underwriter exercised option for warrants to purchase an additional 6,315,788 shares
- Net proceeds expected to be approximately $18.3 million
- Warrants have a $1.10 exercise price, 5-year term, with beneficial ownership limitations
- Offering priced at ~8% discount to the prior close of $1.03
- Company previously disclosed going-concern risk in the related 424B5 filing
Financial Impact
Immediate dilution of ~30% from shares alone; potential further dilution from warrants (up to 48.4M additional shares if exercised). Net cash infusion of ~$18.3M against an $86M market cap.
Risk Factors
- Substantial dilution from shares and warrants
- Going-concern risk as previously disclosed
- Warrant overhang may cap upside
- Dependence on INO-3107 regulatory outcome
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-326785 |
| Document: d253972dex42.htm | 0001193125-26-326785 |
| Document: d253972dex41.htm | 0001193125-26-326785 |
| Document: d253972d8k.htm | 0001193125-26-326785 |
| Document: d253972dex51.htm | 0001193125-26-326785 |
| Document: d253972dex992.htm | 0001193125-26-326785 |
| Document: d253972dex991.htm | 0001193125-26-326785 |
| Document: 0001193125-26-326785-index-headers.html | 0001193125-26-326785 |
| Document: 0001193125-26-326785-index.html | 0001193125-26-326785 |
| Document: 0001193125-26-326785.txt | 0001193125-26-326785 |
Track record
20 reports on INO
7 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +46.23% at T+20 after the Jul 2, 2026 report. 8 of 14 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.39 Now $1.40 +0.72% settles Nov 24
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.40 Now $1.40 −0.01% settles Nov 24
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.41 Now $1.40 −0.71% settles Nov 23
- Nov 10, 20266d ago 8-K Bearish 5/10 Entry $1.48 Now $1.40 +5.08% settles Nov 18
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
- Nov 6, 202610d ago 424B5 Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
- Nov 5, 202611d ago Press Release Bearish 6/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago 424B5 Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago Press Release Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers